SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-15-396804
Filing Date
2015-12-08
Accepted
2015-12-07 20:06:31
Documents
5
Period of Report
2015-12-07
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d58671d8k.htm 8-K 17719
2 EX-1.1 d58671dex11.htm EX-1.1 199366
3 EX-5.1 d58671dex51.htm EX-5.1 8616
4 GRAPHIC g58671ex5_1pg01a.jpg GRAPHIC 7456
5 GRAPHIC g58671ex5_1pg01b.jpg GRAPHIC 16090
  Complete submission text file 0001193125-15-396804.txt   259569
Mailing Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459
Business Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459 617-658-0600
Karyopharm Therapeutics Inc. (Filer) CIK: 0001503802 (see all company filings)

IRS No.: 263931704 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36167 | Film No.: 151273912
SIC: 2834 Pharmaceutical Preparations